Bellevue Group’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-141,125
| Closed | -$5.65M | – | 222 |
|
|
2020
Q4 | $5.65M | Hold |
141,125
| – | – | 0.06% | 124 |
|
|
2020
Q3 | $8.04M | Hold |
141,125
| – | – | 0.11% | 115 |
|
|
2020
Q2 | $10.4M | Hold |
141,125
| – | – | 0.15% | 104 |
|
|
2020
Q1 | $7M | Buy |
141,125
+26,361
| +23% | +$1.31M | 0.14% | 103 |
|
|
2019
Q4 | $8.81M | Hold |
114,764
| – | – | 0.14% | 99 |
|
|
2019
Q3 | $4.58M | Hold |
114,764
| – | – | 0.09% | 112 |
|
|
2019
Q2 | $3.86M | Buy |
+114,764
| New | +$3.86M | 0.07% | 112 |
|